3-[(1-hydroxyethyl-piperazine)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline

ID: ALA217241

PubChem CID: 16090543

Max Phase: Preclinical

Molecular Formula: C28H31N3O7

Molecular Weight: 521.57

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc2c3c(n(CCCN4CCN(CCO)CC4)c(=O)c2cc1OC)-c1cc2c(cc1C3=O)OCO2

Standard InChI:  InChI=1S/C28H31N3O7/c1-35-21-12-17-20(15-22(21)36-2)28(34)31(5-3-4-29-6-8-30(9-7-29)10-11-32)26-18-13-23-24(38-16-37-23)14-19(18)27(33)25(17)26/h12-15,32H,3-11,16H2,1-2H3

Standard InChI Key:  JYHRUUYQZXLFOH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   -4.5751  -20.3991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5762  -21.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8655  -21.6323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8673  -19.9888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1560  -20.3955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1526  -21.2239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4376  -21.6328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7213  -21.2180    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4353  -22.4531    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2730  -19.1629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4443  -19.9762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7227  -20.3898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4505  -19.0724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1087  -19.8304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2831  -19.9122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9698  -18.3994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1452  -18.4775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1980  -19.2350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0244  -19.1429    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1921  -18.3284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4693  -17.9172    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8239  -18.5551    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0103  -21.6271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2850  -21.6321    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2888  -19.9913    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0068  -20.4015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0017  -21.2229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3006  -21.2158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4104  -21.6249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1170  -21.2138    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8313  -21.6227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5385  -21.2109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5377  -20.3885    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8234  -19.9796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1100  -20.3933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2470  -19.9767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9584  -20.3851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6678  -19.9733    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  6  7  1  0
  7  8  1  0
  8 12  1  0
  5  4  2  0
  7  9  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 17  1  0
 11 12  2  0
 10 22  2  0
  4  1  1  0
  8 23  1  0
  5  6  1  0
  2 24  1  0
 10 11  1  0
 25 26  1  0
  1 25  1  0
 12 14  1  0
 24 27  1  0
 13 10  1  0
 23 28  1  0
  2  3  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
  3  6  2  0
 13 14  2  0
  1  2  2  0
 14 15  1  0
 15 18  2  0
  5 11  1  0
 30 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 17 16  2  0
 33 36  1  0
 16 13  1  0
 36 37  1  0
 17 18  1  0
 37 38  1  0
M  END

Associated Targets(Human)

SF-539 (44845 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-62 (47335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SN12C (47755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 521.57Molecular Weight (Monoisotopic): 521.2162AlogP: 1.96#Rotatable Bonds: 8
Polar Surface Area: 102.70Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.68CX LogP: 0.66CX LogD: 0.20
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.37Np Likeness Score: 0.04

References

1. Nagarajan M, Morrell A, Ioanoviciu A, Antony S, Kohlhagen G, Agama K, Hollingshead M, Pommier Y, Cushman M..  (2006)  Synthesis and evaluation of indenoisoquinoline topoisomerase I inhibitors substituted with nitrogen heterocycles.,  49  (21): [PMID:17034134] [10.1021/jm060564z]

Source